ALAlex Luedtke

Alex Luedtke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alex Luedtke has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparing HIV Vaccine Immunogenicity Across Trials With Different Populations and Study Designs

    by Yutong Jin, Alex Luedtke, Zoe Moodie, Holly Janes, David Benkeser

    Safe and effective preventive vaccines have the potential to help stem the HIV epidemic. The efficacy of such vaccines is typically measured in randomized, double‐blind phase IIb/III trials and described as a reduction in newly acquired HIV infections. However, such trials are often expensive, time‐consuming, and/or logistically challenging. These challenges lead to a great interest in immune responses induced by vaccination, and in identifying which immune responses predict vaccine efficacy. These responses are termed vaccine correlates of protection . Studies of vaccine‐induced immunogenicity vary in size and design, ranging from small, early‐phase trials to case‐control studies nested in a broader late‐phase randomized trial. Moreover, trials can be conducted in geographically diverse study populations across the world. Such diversity presents a challenge for objectively comparing vaccine‐induced immunogenicity. To address these practical challenges, we propose a framework that is capable of identifying appropriate causal estimands and estimators, which can be used to provide standardized comparisons of vaccine‐induced immunogenicity across trials. We evaluate the performance of the proposed estimands via extensive simulation studies. Our estimators are well‐behaved and enjoy robustness properties. The proposed technique is applied to compare vaccine immunogenicity using data from three recent HIV vaccine trials.

  • Data Fusion Using Weakly Aligned Sources

    by Sijia Li, Peter B. Gilbert, Rui Duan, Alex Luedtke

    We introduce a new data fusion method that utilizes multiple data sources to estimate a smooth, finite-dimensional parameter. Most existing methods only make use of fully aligned data sources that share common conditional distributions of one or more variables of interest. However, in many settings, the scarcity of fully aligned sources can make existing methods require unduly large sample sizes to be useful. Our approach enables the incorporation of weakly aligned data sources that are not perfectly aligned, provided their degree of misalignment is known up to finite-dimensional parameters. We quantify the additional efficiency gains achieved through the integration of these weakly aligned sources. We characterize the semiparametric efficiency bound and provide a general means to construct estimators achieving these efficiency gains. We illustrate our results by fusing data from two harmonized HIV monoclonal antibody prevention efficacy trials to study how a neutralizing antibody biomarker associates with HIV genotype.


  • Can the potential benefit of individualizing treatment be assessed using trial summary statistics alone?

    by Nina Galanter, Marco Carone, Ronald C Kessler, Alex Luedtke

    Individualizing treatment assignment can improve outcomes for diseases with patient-to-patient variability in comparative treatment effects. When a clinical trial demonstrates that some patients improve on treatment while others do not, it is tempting to assume that treatment effect heterogeneity exists. However, if outcome variability is mainly driven by factors other than variability in the treatment effect, investigating the extent to which covariate data can predict differential treatment response is a potential waste of resources. Motivated by recent meta-analyses assessing the potential of individualizing treatment for major depressive disorder using only summary statistics, we provide a method that uses summary statistics widely available in published clinical trial results to bound the benefit of optimally assigning treatment to each patient. We also offer alternate bounds for settings in which trial results are stratified by another covariate. Our upper bounds can be especially informative when they are small, as there is then little benefit to collecting additional covariate data. We demonstrate our approach using summary statistics from a depression treatment trial. Our methods are implemented in the rct2otrbounds R package.

  • Predicting Homelessness Among Transitioning U.S. Army Soldiers

    by Jack Tsai, Dorota Szymkowiak, Dina Hooshyar, Sarah M. Gildea, Irving Hwang, Chris J. Kennedy, Andrew J. King, Katherine A. Koh, Alex Luedtke, Brian P. Marx, et al.


  • Open Access

    Estimation of subsidiary performance metrics under optimal policies

    by Zhaoqi Li, Houssam Nassif, Alex Luedtke

    In policy learning, the goal is typically to optimize a primary performance metric, but other subsidiary metrics often also warrant attention. This paper presents two strategies for evaluating these subsidiary metrics under a policy that is optimal for the primary one. The first relies on a novel margin condition that facilitates Wald-type inference. Under this and other regularity conditions, we show that the one-step corrected estimator is efficient. Despite the utility of this margin condition, it places strong restrictions on how the subsidiary metric behaves for nearly optimal policies, which may not hold in practice. We therefore introduce alternative, two-stage strategies that do not require a margin condition. The first stage constructs a set of candidate policies and the second builds a uniform confidence interval over this set. We provide numerical simulations to evaluate the performance of these methods in different scenarios.

  • Internet-delivered cognitive behavior therapy versus treatment as usual for anxiety and depression among Latin American university students: A randomized clinical trial.

    by Corina Benjet, Yesica Albor, Libia Alvis-Barranco, Carlos C. Contreras-Ibáñez, Gina Cuartas, Lorena Cudris-Torres, Noé González, Jacqueline Cortés-Morelos, Raúl A. Gutierrez-Garcia, Maria Elena Medina-Mora, et al.

    Untreated mental disorders are important among low- and middle-income country (LMIC) university students in Latin America, where barriers to treatment are high. Scalable interventions are needed. This study compared transdiagnostic self-guided and guided internet-delivered cognitive behavioral therapy (i-CBT) with treatment as usual (TAU) for clinically significant anxiety and depression among undergraduates in Colombia and Mexico. 1,319 anxious, as determined by the Generalized Anxiety Disorder-7 (GAD-7) = 10+ and/or depressed, as determined by the Patient Health Questionnaire-9 (PHQ-9) = 10+, undergraduates (mean [SD] age = 21.4 [3.2]); 78.7% female; 55.9% first-generation university student) from seven universities in Colombia and Mexico were randomized to culturally adapted versions of self-guided i-CBT (n = 439), guided i-CBT (n = 445), or treatment as usual (TAU; n = 435). All randomized participants were reassessed 3 months after randomization. The primary outcome was remission of both anxiety (GAD-7 = 0-4) and depression (PHQ-9 = 0-4). We hypothesized that remission would be higher with guided i-CBT than with the other interventions. Intent-to-treat analysis found significantly higher adjusted (for university and loss to follow-up) remission rates (ARD) among participants randomized to guided i-CBT than either self-guided i-CBT (ARD = 13.1%, χ12 = 10.4, p = .001) or TAU (ARD = 11.2%, χ12 = 8.4, p = .004), but no significant difference between self-guided i-CBT and TAU (ARD = -1.9%, χ12 = 0.2, p = .63). Per-protocol sensitivity analyses and analyses of dimensional outcomes yielded similar results. Significant reductions in anxiety and depression among LMIC university students could be achieved with guided i-CBT, although further research is needed to determine which students would most likely benefit from this intervention. (PsycInfo Database Record (c) 2023 APA, all rights reserved).


  • Efficient estimation of the maximal association between multiple predictors and a survival outcome

    by Tzu-Jung Huang, Alex Luedtke, Ian W. McKeague

    This paper develops a new approach to post-selection inference for screening high-dimensional predictors of survival outcomes. Post-selection inference for right-censored outcome data has been investigated in the literature, but much remains to be done to make the methods both reliable and computationally-scalable in high dimensions. Machine learning tools are commonly used to provide predictions of survival outcomes, but the estimated effect of a selected predictor suffers from confirmation bias unless the selection is taken into account. The new approach involves the construction of semiparametrically efficient estimators of the linear association between the predictors and the survival outcome, which are used to build a test statistic for detecting the presence of an association between any of the predictors and the outcome. Further, a stabilization technique reminiscent of bagging allows a normal calibration for the resulting test statistic, which enables the construction of confidence intervals for the maximal association between predictors and the outcome and also greatly reduces computational cost. Theoretical results show that this testing procedure is valid even when the number of predictors grows superpolynomially with sample size, and our simulations support this asymptotic guarantee at moderate sample sizes. The new approach is applied to the problem of identifying patterns in viral gene expression associated with the potency of an antiviral drug.


  • Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials

    by Christine B. Turley, LaKesha Tables, Trevon Fuller, Lisa J. Sanders, Hyman Scott, Amaran Moodley, Amanda Woodward Davis, Brett Leav, Jacqueline Miller, Kathryn Schoemaker, et al.


  • Open Access

    Estimating the efficiency gain of covariate-adjusted analyses in future clinical trials using external data

    by Xiudi Li, Sijia Li, Alex Luedtke

    We present a framework for using existing external data to identify and estimate the relative efficiency of a covariate-adjusted estimator compared to an unadjusted estimator in a future randomized trial. Under conditions, these relative efficiencies approximate the ratio of sample sizes needed to achieve a desired power. We develop semiparametrically efficient estimators of the relative efficiencies for several treatment effect estimands of interest with either fully or partially observed outcomes, allowing for the application of flexible statistical learning tools to estimate the nuisance functions. We propose an analytic Wald-type confidence interval and a double bootstrap scheme for statistical inference. We demonstrate the performance of the proposed methods through simulation studies and apply these methods to estimate the efficiency gain of covariate adjustment in Covid-19 therapeutic trials.


  • Open Access

    Adversarial meta-learning of Gamma-minimax estimators that leverage prior knowledge

    by Hongxiang Qiu, Alex Luedtke

    Bayes estimators are well known to provide a means to incorporate prior knowledge that can be expressed in terms of a single prior distribution. However, when this knowledge is too vague to express with a single prior, an alternative approach is needed. Gamma-minimax estimators provide such an approach. These estimators minimize the worst-case Bayes risk over a set Γ of prior distributions that are compatible with the available knowledge. Traditionally, Gamma-minimaxity is defined for parametric models. In this work, we define Gamma-minimax estimators for general models and propose adversarial meta-learning algorithms to compute them when the set of prior distributions is constrained by generalized moments. Accompanying convergence guarantees are also provided. We also introduce a neural network class that provides a rich, but finite-dimensional, class of estimators from which a Gamma-minimax estimator can be selected. We illustrate our method in two settings, namely entropy estimation and a prediction problem that arises in biodiversity studies.